Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure: Cell
LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus | Nature Communications
Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes - ScienceDirect
Human Islet Expression Levels of Prostaglandin E2 Synthetic Enzymes, But Not Prostaglandin EP3 Receptor, Are Positively Correlated with Markers of β-Cell Function and Mass in Nondiabetic Obesity | ACS Pharmacology & Translational
Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failure | Experimental & Molecular Medicine
Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function | PLOS Biology
PDF) Assessment of disturbed glucose metabolism and surrogate measures of insulin sensitivity in obese children and adolescents
Frontiers | Diabetic cardiomyopathy: Clinical phenotype and practice
A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry - ScienceDirect
Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population
IJMS | Free Full-Text | Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes
IJMS | Free Full-Text | Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus
Targeting inflammation in the treatment of type 2 diabetes: time to start | Nature Reviews Drug Discovery
Strategies for durable β cell replacement in type 1 diabetes | Science
Phosphatidylinositol metabolism of the renal proximal tubule S3 segment is disturbed in response to diabetes | Scientific Reports
Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress
Molecules | Free Full-Text | Progress in Metabonomics of Type 2 Diabetes Mellitus
Targeting innate immune mediators in type 1 and type 2 diabetes | Nature Reviews Immunology
IJMS | Free Full-Text | Stem Cell-Derived Islets for Type 2 Diabetes
Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population